The Asian Scientist 100
Andrew Nee
Professor
Institution
National University of Singapore
Country
Singapore
Field
Engineering
Nee, an expert on the use of computer-aided design in precision engineering as well as an augmented reality pioneer, received the US Society of Manufacturing Engineers Gold Medal in 2014 for his lifetime contributions to manufacturing research.
(Photo: National University of Singapore)
Related articles
Kenji Doya Receives 2018 Donald O. Hebb Award
The award recognizes Professor Kenji Doya’s achievements in developing artificial neural networks.
When Writers Take On Numbers
Science writers, don’t be afraid to question the statistical interpretations you read in scientific journal articles—researchers are as intimidated by them as you are.
Future-Proof Me
Our columnist Alice thinks that coding and writing skills, coupled with emotional intelligence and cultural sensitivity, are keys to survival in a globally connected and digital future.
A Dose Of (Virtual) Reality
With virtual reality (VR) and augmented reality (AR) technologies blurring the seams between reality and fantasy, everyone from startups to academia and even NASA wants a slice of the action.
Could ‘Bee Soup’ Reading Save The Bees?
Mitochondrial genome sequencing has made it feasible to track wild bee populations over time, aiding conservation efforts.
A Deep Dive Into Tech
Asian Scientist Magazine finds out how Dr. Finian Tan—chairman of Vickers Venture Partners and one of Baidu’s earliest backers—brings his technical background and industry knowledge to bear on multimilliondollar investment decisions.
Redefining The Genetic Landscape Of Pancreatic Cancer
Classifying pancreatic cancer into four subtypes based on whole genome sequencing could help improve the specificity of existing treatments.
WuXi & Lilly To Develop Cardiovascular Drug In China
As part of Lilly's ‘In China, For China’ strategy, the small molecule drug is intended to help the 276 million Chinese patients affected by high cholesterol.
When T Spells Trouble For Cancer
The world’s largest clinical trial of T-cells for cancer is being conducted by a Singapore-based biotech company, Tessa Therapeutics. Sim Shuzhen finds out more.